Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial. - Wikidata - wikimedia - TriplyDB

Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.

Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.

http://www.wikidata.org/entity/Q36087056

about

Acute development of collateral circulation and therapeutic prospects in ischemic stroke Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations Neuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence.Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke.Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke.Inflammatory Disequilibrium in Stroke Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery.Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.Sphingosine-1-Phosphate Signaling in Endothelial Disorders.Clinical pharmacology, efficacy, and safety aspects of sphingosine-1-phosphate receptor modulators.Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets.Clinical Trials of Immunomodulation in Ischemic Stroke.Natalizumab: a new therapy for acute ischemic stroke?Antigen Presentation After Stroke.Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury.Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke.Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation.Neuroinflammation.An engineered S1P chaperone attenuates hypertension and ischemic injury.Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway.Cell-based and pharmacological neurorestorative therapies for ischemic stroke.Emerging Role of Immunity in Cerebral Small Vessel Disease.Fingolimod targets cerebral endothelial activation to block leukocyte recruitment in the central nervous system.Extending the Time Window for Endovascular and Pharmacological Reperfusion.Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous System.Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial.Stroke-induced immunosuppression and poststroke infection.Refocusing Neuroprotection in Cerebral Reperfusion Era: New Challenges and Strategies.Epigenetic regulation of inflammation in stroke.Immunotherapy of experimental and human stroke with agents approved for multiple sclerosis: a systematic review.The meningeal and choroidal infiltration routes for leukocytes in stroke.Hypothermia and brain inflammation after cardiac arrest The “inflammatory penumbra” in ischemic stroke: From clinical data to experimental evidence

P2860

Q26749051-891ABBAB-6D6E-41AF-8ACF-87097D228FC7 Q26765300-B2E18481-1204-4587-BCA0-139EAA5A32A7 Q36256704-0F4C0BB7-D800-4FDA-B9E2-BA93A5896760 Q36743512-67C28087-CA77-4935-A720-3F72BF5D8FE5 Q37209163-84FC89B7-509F-41B3-B456-9BF0D7A8D2EF Q37474699-477B87D7-C9BA-4E16-93F8-E7DFD9A4F868 Q37551932-86E543D3-8F3C-4FD5-B21D-F35CDE0A7695 Q38374295-B62EF596-D698-4521-AA97-9EE1CC43A036 Q38791052-0456C958-31C5-46C2-8CAC-057174DE729D Q38817761-C237305B-BF2D-4DC6-B0A4-5FD7E8532BED Q38850104-8C033AAE-E1FA-4D05-A2E5-3D07FF992551 Q38875349-288D6E74-147D-4EC1-98A5-1980BD84CA7A Q38895854-74983A7A-E762-4BC4-829A-FDA2B59D635F Q38914132-A9F90AA4-F7B7-4401-AE68-D97DE0198B6D Q38925065-2FED6837-5682-4615-BEA3-C16385F46C70 Q41170285-559BB45D-BD8C-4351-B588-DC549A9320E1 Q41314097-0CA066DB-5168-457A-9437-0C80D2ADC08F Q41665385-8AE2C5EF-AE37-4EFE-8B23-9E58D60F1071 Q42347793-F1AF029C-7A84-4E28-AA23-A3F0B34BDD0E Q45423411-5A3DD2F2-0271-44A1-AE07-B5E73DCB395F Q47428394-6B71821E-799F-4980-9492-2A33C849DEDB Q48128873-8520E2D1-6DE9-44A0-BF07-881B95D00E19 Q49408736-F44B5692-155B-4DEA-BD10-73E4F06A8835 Q49977461-497E0E96-134F-4D26-8111-739FDDE84C0E Q51572286-3E8EF6BE-33AF-44C9-A4ED-58A24AE10E34 Q51765579-4AADEC60-E19C-4556-B458-6E9353EC5975 Q52092970-46D8ABF2-A4EE-4EF7-9C27-BBF2736E5F57 Q52620332-9B28B054-F8EC-46A9-90CD-CBE6585C9CA7 Q54967560-DC8F3A50-5E39-401D-AA73-6017CAAD0F4B Q55209717-DACF468B-D743-4003-8874-6234F5C3C53D Q55322373-7CD686CE-9BA5-4FF7-B0B5-96F58090F3EF Q55514994-3CE55C9A-E86D-4980-A4BA-F184CD388950 Q57149107-6A6622C2-F13A-42AF-BD63-29082E65012B Q58179746-D7695608-0F94-4FB0-9C4D-E1E34472F0A7

P2860

Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.

http://www.wikidata.org/entity/Q36087056

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Combination of the Immune Modu ...... schemic Stroke: A Pilot Trial.

@ast

Combination of the Immune Modu ...... schemic Stroke: A Pilot Trial.

@en

type

label

Combination of the Immune Modu ...... schemic Stroke: A Pilot Trial.

@ast

Combination of the Immune Modu ...... schemic Stroke: A Pilot Trial.

@en

prefLabel

Combination of the Immune Modu ...... schemic Stroke: A Pilot Trial.

@ast

Combination of the Immune Modu ...... schemic Stroke: A Pilot Trial.

@en

P1433

Q36087056-3D6DE21E-604E-4DE9-9BF4-659C059ECB3D

P1476

Q36087056-ED61E267-3557-44B8-83F5-E61F9E79EEB6

P2093

Q36087056-1ACFBA8A-459F-4255-9F7D-FBDD82C79175

Q36087056-2F9ABD42-44FC-473B-BE85-F21DAB56BA41

Q36087056-6683C1FF-1F21-4299-A605-8EBDDD712FD7

Q36087056-69467A43-8019-4027-B92C-CF5C37822671

Q36087056-8A2437B6-5FB1-49CA-9EFB-FF35E216C7B5

Q36087056-9C5CC680-4D3D-47F3-9C44-E02025E59F66

Q36087056-B8E8E788-2E2E-49B7-88E6-B330E1BB3514

Q36087056-CDBBF387-09D7-41AD-BB79-EC686C7E3483

Q36087056-D4A4F2B9-304A-4E0F-B168-E1D8ED227B3F

Q36087056-D821E24C-ED66-42A6-AC8A-774B24AC95BC

P2860

Q36087056-089C3A98-A52C-402D-A966-9D646DAF402D

Q36087056-0B85A432-F9BA-42DD-A8F6-A343DC8D35EF

Q36087056-179F93D0-3F70-4005-8C40-F7E33F427462

Q36087056-21C7EBDB-E1AF-4A51-9840-A768937DE3B7

Q36087056-2A78F606-DE11-43A7-BFCA-28A5678199BF

Q36087056-363E07E5-E898-483A-8A43-B9856E063A39

Q36087056-3E90A7F7-9C55-4733-A54E-EFF8350BABF5

Q36087056-4DD35826-3683-4861-B429-65803CD6FC5C

Q36087056-5063E630-9094-45DF-8F0B-F14B301EB1AB

Q36087056-55643EF0-A311-47A1-A67C-B93333BC7A13

P304

Q36087056-44324908-3E97-431F-B1DF-225736EE3C42

P31

Q36087056-1CC5F85F-450E-44EF-A4E2-46A71994A452

P356

Q36087056-49FA7298-E233-470C-A353-DC40A9714F7D

P407

Q36087056-C3C023E7-65EA-4816-AF1B-FC08E47CB4B8

P433

Q36087056-EF05697A-FD0F-482A-812F-A3C021A98DCC

P478

Q36087056-9FDE3C62-3F11-4323-89B1-11E2FD23019B

P577

Q36087056-7ACE7DAF-E8DD-4A01-A3B0-49942366ED46

P698

Q36087056-2FC91E2D-E234-45AC-A0CD-797C92241644

P932

Q36087056-AC3F0D2C-7344-4CF1-986F-62668B9E09AB

P356

CIRCULATIONAHA.115.016371

P1433

P1476

Combination of the Immune Modu ...... schemic Stroke: A Pilot Trial.

@en

P2093

Decai Tian

http://www.w3.org/2001/XMLSchema#string

Deren Huang

http://www.w3.org/2001/XMLSchema#string

Fu-Dong Shi

http://www.w3.org/2001/XMLSchema#string

Guoqiang Chang

http://www.w3.org/2001/XMLSchema#string

Na Sun

http://www.w3.org/2001/XMLSchema#string

Qiang Liu

http://www.w3.org/2001/XMLSchema#string

Wei Han

http://www.w3.org/2001/XMLSchema#string

Xiaolin Xu

http://www.w3.org/2001/XMLSchema#string

Ying Fu

http://www.w3.org/2001/XMLSchema#string

Yinhua Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

The immunology of stroke: from mechanisms to translation

Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.

Factors influencing haemorrhagic transformation in ischaemic stroke.

Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.

Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.

Impact of an immune modulator fingolimod on acute ischemic stroke.

Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.

Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.

P304

1104-1112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.115.016371

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26202811

http://www.w3.org/2001/XMLSchema#string

P932

4580515

http://www.w3.org/2001/XMLSchema#string